SCHEMBL22860417

SCHEMBL22860417

CSc1ncc(CO)c(NCC2CCCCC2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.47
▸ PPARG P37231 1/20 0.46
▸ APP P05067 1/20 0.39
▸ JAK2 O60674 4/20 0.38
▸ JAK1 P23458 4/20 0.38
▸ JAK3 P52333 3/20 0.38
▸ UTS2R Q9UKP6 1/20 0.36
▸ TLR7 Q9NYK1 1/20 0.36
▸ GBA1 P04062 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ASPH Q12797 1/20 0.36
▸ RIOX2 Q8IUF8 1/20 0.36
▸ KDM8 Q8N371 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ GRM4 Q14833 1/20 0.36
▸ SYK P43405 1/20 0.35
▸ CD38 P28907 1/20 0.35
▸ LDHA P00338 1/20 0.34
▸ LDHB P07195 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16120575 0.93 HTT (0.50) HTTPPARGJAK2JAK3UTS2R
SCHEMBL16414978 0.83 HTT (0.42) HTTPPARGJAK2JAK3
SCHEMBL16414977 0.83 HTT (0.42) HTTPPARGJAK2JAK3
SCHEMBL4713140 0.82 GABBR2 (0.46) HTTPPARGJAK2JAK3KDM4E
SCHEMBL4711841 0.82 GABBR2 (0.46) HTTPPARGJAK2JAK3KDM4E
SCHEMBL2622288 0.80 GABBR2 (0.47) HTTPPARGJAK2JAK3KDM4E
SCHEMBL4076223 0.80 PPARG (0.43) PPARGAPPJAK2JAK1JAK3
SCHEMBL22860416 0.80 PPARG (0.46) PPARGAPPJAK2JAK1JAK3
SCHEMBL1521623 0.78 HTT (0.55) HTTKDM4EMEN1KMT2ASYK
SCHEMBL22860693 0.77 MERTK (0.46) HTTPPARGJAK2JAK3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3993802-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Nuvation Bio Inc. (US) 2022-05-11 — — EP disclosed
CN-114340634-A Heterocyclic compounds as kinase inhibitors 诺维逊生物股份有限公司 2022-04-12 — — CN disclosed
WO-2021003314-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS NUVATION BIO INC. (US) 2021-01-07 — — WO disclosed
Send feedback